Whooping Cough: all 290 studies
Page 1 of 3. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.
- A Phase II Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)RecruitingNCT07894055Phase 2
- A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine AdsorbedRecruitingNCT07891104Phase 1/2
- Assessment of the Acceptability of, and Factors Associated With, Recommended Vaccinations During Pregnancy in Maternity Units in the Ile-de-France RegionNot yet recruitingNCT07882186
- Safety and Immunogenicity of a Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Recombinant Poliomyelitis and Haemophilus Influenzae Type b (Hib) Vaccine (SIIPL DTwP-HepB-rPV-Hib)RecruitingNCT07855172Phase 1/2
- Study of BK1803 in Healthy InfantsRecruitingNCT07793513Phase 3
- A Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined VaccineNot yet recruitingNCT07744347
- Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months OldNot yet recruitingNCT07621341Phase 4
- A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)Not yet recruitingNCT07492303Phase 1
- Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) VaccineNot yet recruitingNCT07418372Phase 1/2
- Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT07358910
- Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical TrialRecruitingNCT07112144Phase 3
- A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy AdultsRecruitingNCT06997627Phase 1/2
- Study of Concomitant Administration of the sIPV and DTaP or MMRNot yet recruitingNCT06920069Phase 4
- Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella PertussisRecruitingNCT06827470Phase 1
- Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of AgeNot yet recruitingNCT06618196Phase 2
- Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old InfantsRecruitingNCT06605755Not applicable
- The Optimal Timing of Vaccination in PregnancyRecruitingNCT06466629
- Prevalence and Impact of Pertussis and RSV on Asthma Severity and ControlRecruitingNCT06286007
- Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined VaccineRecruitingNCT06184542Phase 1
- Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning StrategyNot yet recruitingNCT06114160
- A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy AdultsNot yet recruitingNCT05952596Phase 1
- Impact of Bacterial Expression and Immune Response in the Severity of PertussisRecruitingNCT05897879Not applicable
- Pediatric Pertussis in Ambulatory SettingsRecruitingNCT04807712
- Pertussis Challenge Study in Adults Vaccinated With BPZE1CompletedNCT05461131Phase 2Results posted
- Establishing a Controlled Human Infection Model of Bordetella PertussisCompletedNCT05136599Phase 1Results posted
- Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age ChildrenCompletedNCT05116241Phase 2Results posted
- Increasing Influenza and Tdap Vaccination of Pregnant WomenCompletedNCT04444518Not applicableResults posted
- Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and InfantsCompletedNCT04398706Phase 2Results posted
- Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United StatesCompletedNCT03973905Results posted
- Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy AdultsCompletedNCT03942406Phase 2Results posted
- Confirmatory Study of BK1310 in Healthy InfantsCompletedNCT03891758Phase 3Results posted
- Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their InfantsCompletedNCT03589768Phase 2Results posted
- Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy AdultsCompletedNCT03541499Phase 2Results posted
- Seroprevalence of Bordetella Pertussis Antibodies and Anti-pertussis Antibody Response After a Single Dose of Tdap in Pregnant Thai WomenCompletedNCT03498300Early Phase 1Results posted
- The Safety of Boostrix Following Routine Immunization of Pregnant WomenCompletedNCT03463577Results posted
- Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian SubjectsCompletedNCT03311659Phase 3Results posted
- Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy InfantsCompletedNCT02907216Phase 4Results posted
- A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in RussiaCompletedNCT02858440Phase 3Results posted
- Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-deliveryCompletedNCT02853929Phase 4Results posted
- Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant WomenCompletedNCT02783170Phase 4Results posted
- Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)CompletedNCT02759354Phase 3Results posted
- Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy SubjectsCompletedNCT02587520Phase 1/2Results posted
- Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis VaccineCompletedNCT02453048Phase 1Results posted
- Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)CompletedNCT02382913Phase 1Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant WomenCompletedNCT02377349Phase 4Results posted
- Study of BK1301 (DTaP Vaccine) as a Booster in AdolescentsCompletedNCT02118961Phase 3Results posted
- Boostrix® Pregnancy RegistryCompletedNCT02096276Results posted
- Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years OldCompletedNCT02089347Phase 3Results posted
- A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in HungaryCompletedNCT02014519Not applicableResults posted
- Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at BirthCompletedNCT01948193Phase 3Results posted
- Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in ChinaCompletedNCT01933776Phase 1Results posted
- Seroepidemiological Study of Pertussis and Other Infectious DiseasesCompletedNCT01929473Results posted
- Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in KoreaCompletedNCT01929291Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of AgeCompletedNCT01767376Phase 3Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young AdultsCompletedNCT01755689Phase 3Results posted
- Tdap Vaccine in Post-Partum WomenCompletedNCT01711645Phase 4Results posted
- Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in AdolescentsCompletedNCT01689324Phase 1/2Results posted
- Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of AgeCompletedNCT01659996Phase 4Results posted
- Immunogenicity of Adacel® and BOOSTRIX® Vaccines in AdolescentsCompletedNCT01629589Phase 4Results posted
- Pertussis Infection in Adolescents and Adults With Prolonged CoughCompletedNCT01597687Not applicableResults posted
- Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 YearsCompletedNCT01529645Phase 1Results posted
- Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)CompletedNCT01480258Phase 3Results posted
- Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy InfantsCompletedNCT01444781Phase 3Results posted
- Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous DoseCompletedNCT01439165Phase 4Results posted
- Regulatory Post-Marketing Surveillance Study for TETRAXIM™CompletedNCT01437423Phase 4Results posted
- A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in AdolescentsCompletedNCT01424644Phase 4Results posted
- Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type BCompletedNCT01362517Phase 3Results posted
- Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood VaccinationCompletedNCT01357720Phase 4Results posted
- Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of AgeCompletedNCT01346293Phase 3Results posted
- Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)CompletedNCT01341639Phase 3Results posted
- A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)CompletedNCT01340937Phase 3Results posted
- Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)CompletedNCT01337167Phase 3Results posted
- Study of Adacel® Vaccine Administered to Persons 10 Years of AgeCompletedNCT01311557Phase 4Results posted
- A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American InfantsCompletedNCT01177722Phase 3Results posted
- Post Marketing Surveillance for ADACEL™ in South KoreaCompletedNCT01137435Phase 4Results posted
- Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in RussiaCompletedNCT01094171Phase 4Results posted
- A Study to Assess the Safety of Adacel® VaccineCompletedNCT01040052Phase 3Results posted
- Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian InfantsCompletedNCT00831753Phase 3Results posted
- Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean InfantsCompletedNCT00831311Phase 2Results posted
- Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™CompletedNCT00802867Phase 4Results posted
- Immunogenicity and Safety of Adacel Polio VaccineCompletedNCT00797511Phase 3Results posted
- Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap VaccineCompletedNCT00777257Phase 4Results posted
- Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™CompletedNCT00772928Phase 3Results posted
- Retrospective Survey of Safety of Fourth Dose Pentacel® in ChildrenCompletedNCT00772369Results posted
- Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous DoseCompletedNCT00712959Phase 4Results posted
- Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™CompletedNCT00654901Phase 3Results posted
- Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio VaccineCompletedNCT00635128Phase 4Results posted
- Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish InfantsCompletedNCT00619502Phase 3Results posted
- Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.CompletedNCT00610168Phase 4Results posted
- Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™CompletedNCT00534833Phase 3Results posted
- A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In AdolescentsCompletedNCT00518180Phase 3Results posted
- Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino InfantsCompletedNCT00514709Phase 3Results posted
- Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/HibCompletedNCT00473668Phase 3Results posted
- Vanderbilt Pertussis Exposure Study: PEP in Vaccinated Healthcare Workers Following Pertussis ExposureCompletedNCT00469274Not applicableResults posted
- Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of AgeCompletedNCT00467519Phase 3Results posted
- A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and OlderCompletedNCT00457249Phase 4Results posted
- Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)CompletedNCT00432042Phase 3Results posted
- Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy InfantsCompletedNCT00404651Phase 3Results posted
- Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai InfantsCompletedNCT00401531Phase 3Results posted
- Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female SubjectsCompletedNCT00369824Phase 3Results posted